Study objective: To evaluate the effect of parity, menopausal status, menstrual cycle phase, cervical or uterine pathology and duration of procedure on pain experienced during office hysteroscopy.
Introduction
Office hysteroscopy is considered a valuable addition to the outpatient diagnostic modalities in gynecology clinic. Several studies have shown that office hysteroscopy by the vaginoscopic approach is a well accepted tolerable procedure without the need of analgesia or pain medication with a limited failure rate of less than 4% (1, 2) . However, in some patients, premedication or simultaneous use of local analgesia as cervical block may be necessary to accomplish the procedure (3).
Cicinelli et al. (4) , based on an experience of 8000 cases of office hysteroscopy, reported that approximately 10% of the patients experienced mild pain, and 0.5% of the cases experienced severe pain. Similarly, several studies have shown that failure rate and pain are much reduced with the use of smaller diameter scopes less than 4 mm as compared with traditional hysteroscopy (5) (6) (7) .
Anticipation for the need of premedication or additional analgesia to relieve pain during the procedure may reduce the failure rate of office hysteroscopy. This reduces psychological burden on the patient and increases the effectiveness of the medical service provided. In evaluating different predictors of pain, several studies have reported controversial results for the significance of clinical variables, such as parity, mode of delivery and menopausal status, presence of cesarean section scar etc (8, 9) . Moreover, the effect of surgeon's experience and diameter of the scope have been controversial in other studies (10) (11) (12) . The aim of this study was to evaluate the effect of patient parity, menopausal status, menstrual cycle phase, cervical or uterine pathology and duration of procedure on pain experienced during office hysteroscopy.
Methods
This prospective study, performed between July 2012 and July 2013, included 254 patients who were referred to the hysteroscopy outpatient clinic of Cairo University hospital, Egypt. The study protocol was approved by the institutional ethics committee and informed consent was obtained from the patients. Women with infertility, abnormal uterine bleeding, abnormal finding on ultrasound examination or hysterosalpingography and missed intrauterine device were recruited to the study. Contraindications for the office hysteroscopy were severe bleeding, history of severe cardiovascular disease, endometrial neoplasia and suspicion of pregnancy. Moreover, patients with a history or suspicion of pelvic inflammatory disease were excluded from the study.
Office hysteroscopy was performed using the vaginoscopic approach as described by Betocchi and Selvaggi in 1997 (13) . A rigid 2.9 mm scope Hopkins type II forward oblique lens (Karl Storz, Tuttlingen, Germany) and outer sheath diameter of 4.3 mm diagnostic office hysteroscopy was used in the procedure (code 26153BI). Saline was used as a distending medium and the pressure used was set between 80 and 100 mmHg. No premedication was given to the patient during their waiting time and cervical preparation was not done.
In all the patients, office hysteroscopy started by introducing the scope into the vagina and performing vaginoscopy followed by passage of the scope through the cervix slowly allowing the fluid distend the cervix slowly while performing cerviscopy. Since the passage of the scope through the internal os was the most painful part of the procedure care was taken to pass the scope as slowly without touching the uterine wall at any time. Throughout the procedure a visual contact was maintained with the patient to observe the patient response to pain and tolerability while interacting with the patient explaining the findings of the procedure. At the end of the procedure the total duration of the procedure was recorded.
Immediately after the end of procedure, the patients were asked to score pain experienced during the procedure according to a 10 cm visual analog score (VAS) as follows; zero = no pain, 1-3 = mild discomfort, 4-7 = moderate pain, 8-9 = severe pain, 10 = intolerable pain.
Patients were divided into two groups; group A if no pain, mild discomfort or moderate pain were felt during procedure (pain score 0-7) and group B if patients experienced severe or intolerable pain (pain score 8-10). Failure of the procedure was defined as inability to complete the procedure either because of the intolerable pain or inability to introduce the scope into the uterine cavity.
Statistical analysis was performed via v 2 test or Student t-test as appropriate. A Yates correction equation was used when the expected frequency was less than 5. P value <0.05 was considered statistically significant. Multivariate analysis was done using multiple logistic regression to detect factors associated with severe and intolerable pain and failure of hysteroscopy. All statistical calculations were performed using Excel version 7 (Microsoft, New York, NY, USA) and SPSS (SPSS, Chicago, IL, USA).
Results
Eighty-six patients (33.86%) reported no or mild pain, 118 patients (46.46%) reported moderate pain, 44 patients (17.32%) experienced severe pain and 6 patients (2.36%) experienced intolerable pain necessitating stoppage of the procedure. There were no significant differences in the age or body mass index between patients with severe or intolerable pain and patients with mild or moderate pain (33.52 ± 11.42 vs. 33.90 ± 10.04, P value = 0.831 and 31.7 ± 5.64 vs. 30.95 ± 4.71, P value = 0.39 respectively).
The indications for referral of the patients to the hysteroscopy clinic were infertility (53.15%), reproductive age bleeding (12.99%), post-menopausal bleeding (5.91%), preparation for in vitro fertilization embryo transfer (IVF-ET) (11.02%), 2nd look hysteroscopy (5.12%), missed intrauterine contraceptive device (IUCD) (4.33%), suspected endometrial polyp (3.94%), or intrauterine synechiae (2.36%), chronic pelvic pain (0.79%) and amenorrhea (0.39%).
At the time of hysteroscopy examination, 181 patients were in the proliferative phase (71.26%), 55 were in the secretory phase (21.65%), 15 were menopausal (5.91%) and 3 were amenorrheic (1.18%).
Cervical pathology was present in 48 patients (18.9%). Twenty-three patients had cervical stenosis at internal os (9.06%), eight patients had cervical polyp (3.15%), six patients had adhesions (2.36%), five patients had nabothian follicles (1.97%), three patients had hypertrophied cervix of chronic infection (1.18%), two patients had stenosis at external os (0.79%) and one patient had cervical septum (0.39%).
Uterine pathology was detected in 117 patients (46.06%). Anatomical abnormalities detected were arcuate uterus (7.48%), subseptate uterus (5.91%), bicornuate uterus (1.97%), unicornuate uterus (1.57%), hypoplastic uterus (0.39%) and tubular cavity (0.79%). Other abnormalities detected were endometrial polyps (9.84%), submucous myoma (5.91%), polypoidal endometrium (3.94%), distorted irregular cavity (1.18%), intrauterine synechiae (3.94%), endometritis (2.76%) and intracavitary bones from previous conception (0.39%).
Bivariate analysis revealed that nulliparous patients had a higher risk of developing severe or intolerable pain compared with non-nulliparous patients (26.67% vs. 11.76%, P value = 0.003). Moreover, severe or intolerable pain was reported more frequently in patients with cervical pathology and duration of procedure more than 2 min (39.58% vs. 15.05%, P value = 0.0001 and 25.22% vs. 15.11%, P value = 0.044 respectively).
No association was detected between the presence of uterine pathology or menstrual phase and the occurrence of severe or intolerable pain (Table 1) .
Bivariate analysis revealed that the failure of hysteroscopy was reported more frequently in patients with cervical pathology (12.50% vs. 0%, P value = 0.0001). Moreover, no correlation was determined between nulliparity, duration of procedure, uterine pathology, menstrual phase or menopausal state and failure of hysteroscopy (Table 2) .
Multivariate analysis using multiple logistic regression revealed that nulliparity, cervical pathology and duration of procedure more than 2 min were strongly associated with severe or intolerable pain (Table 3 ). On the other hand, no correlation was found between failure of hysteroscopy and any predictor factor.
Discussion
The data presented in this study revealed that office hysteroscopy is a painless procedure in most of the patients. In our study, 33.86% of the patients have no or mild pain and 46.46% have moderate pain, only 17.32% of patients experienced severe pain and 2.32% of patients experienced intolerable pain necessitating stoppage of the procedure. The results of our study are in accordance with several recent studies (Table 4) . A prospective study including 558 patients undergoing office hysteroscopy revealed that 32.3% of patients experienced severe pain (14) . De Carvalho Schettini et al. reported that 31.58% of patients undergoing office hysteroscopy suffered moderate or severe pain (10) .
In our study, 26.67% of nulliparous women and 11.76% of non-nulliparous women have severe or intolerable pain (risk ratio 2.27, 95% CI (1.29, 3.99), P = 0.003). Moreover, 39.58% of women with cervical pathology experienced severe or intolerable pain compared with 15.05% of cases with no cervical pathology (relative risk 2.63, 95% CI (1.63, 4.24), P value = 0.0001). Multivariate analysis confirmed a direct relation of nulliparity and the presence of cervical pathology with severe and intolerable pain. The results of our study support the hypotheses that the relation between the cervical width and the diameter of the scope is the most important predicting factor for the pain associated with office hysteroscopy. The wider external os, cervical canal and internal os in multiparous women compared with nulliparous women allow easier passage of hysteroscope. On the other hand, the presence of stenosis of external or internal os or cervical lesion narrowing the cervical canal makes the passage of the hysteroscope more difficult and therefore more painful. Several studies have shown that higher tolerability, acceptability and lower pain and failure rate are associated with the use of smaller scope or in multiparous women with wide cervical canal, internal os and external os. Campo et al., in a prospective randomized controlled trial study compared traditional diagnostic hysteroscope (5 mm scope) versus mini-hysteroscope (2.7 mm rigid scope or fiberoptic hysteroscope of 2 mm) (8) . They studied the effect of parity and history of vaginal delivery and surgeon experience in relation to the pain during the procedure and success rate in both settings. They reported that both parity and history of vaginal delivery were important factors in relation to pain when using traditional hysteroscope but were no longer significant factors when minihysteroscope was used. A prospective study including 171 women undergoing office hysteroscopy revealed that menopause, speculum examination and nulliparity are the main factors associated with unacceptable pain (10) .
In contrast to our findings, Cicinelli et al. reported that the nulliparity is not a risk factor of pain at hysteroscopy (1) . Moreover, Torok and Major, concluded that there is no evidence that parity, menopausal status, or the thickness of the instrument influence the level of experienced pain (9) .
In our sample of patients, severe or intolerable pain was reported more frequently in patients who endured procedure more than 2 min. A prospective study including 558 patients undergoing office hysteroscopy without anesthesia reported that the duration of hysteroscopy was significantly longer in patients who experienced severe pain (14) . On the other hand, several authors reported that the duration of the procedure has no direct correlation with severity of pain (10, 15, 16) .
No correlation was found between menstrual cycle phase, uterine pathology and menopausal state and severe or intolerable pain. Torok and Major, reported no significance of the menopausal state for pain prediction during office hysteroscopy (9) . In contrast to our findings, two prospective studies revealed that menopause is correlated with severe pain during office hysteroscopy (1, 10) .
In the present study, six patients experienced intolerable pain necessitating stoppage of the procedure. All these patients had cervical pathology. Although, bivariate analysis revealed that patients with cervical pathology have a higher risk of failure of office hysteroscopy compared with patients with no cervical pathology (12.50% vs. 0%, P value = 0.0001), the multivariate analysis revealed that cervical pathology had no direct correlation with intolerable pain and failure of office hysteroscopy. Moreover, bivariate analysis and multivariate analysis revealed no correlation between nulliparity, duration of procedure, uterine pathology, menstrual phase or menopausal state and failure of office hysteroscopy.
In conclusion, nulliparity, presence of cervical pathology and duration of the procedure more than 2 min are associated with severe or intolerable pain during office hysteroscopy. On the other hand, menstrual phase, menopausal status and presence of uterine pathology are not predictors of occurrence of severe or intolerable pain during office hysteroscopy. We think that the nulliparous patients and patients with cervical pathology require special pain management considerations during office hysteroscopy. The small number of cases with a failure of office hysteroscopy (n = 6) may be the cause of failure of detection of correlation between cervical pathology and failure of office hysteroscopy by multivariate analysis. Further larger studies are needed to detect the correlation of cervical pathology and failure of office hysteroscopy.
